Elevated Pretreatment Fibrinogen-to-Lymphocyte Percentage Ratio Predict Tumor Staging and Poor Survival in Non-Small Cell Lung Cancer Patients with Chemotherapy or Surgery Combined with Chemotherapy

PURPOSE: The objective of our study was to assess the association between lymphocyte percentage (LY%), fibrinogen (FIB), fibrinogen-to-lymphocyte percentage ratio (FLR) and the tumor staging and the clinical outcome role in non-small cell lung cancer (NSCLC) patients with chemotherapy or surgery com...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Meifang, Yang, Jie, Wan, Lagen, Zhao, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232845/
https://www.ncbi.nlm.nih.gov/pubmed/34188545
http://dx.doi.org/10.2147/CMAR.S308659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232845/
https://www.ncbi.nlm.nih.gov/pubmed/34188545
http://dx.doi.org/10.2147/CMAR.S308659

Ejemplares similares